Matthew Majewski

Vice President

New York
+1-212-520-7260

Mr. Matthew Majewski has a track record of providing life science clients with analytically based solutions to their strategic issues.

He has led a range of strategy engagements from product related topics to corporate challenges. Prior to joining CRA, Mr. Majewski was a consultant at Stratēgyx where he developed managed market strategies for pre-launch products and designed managed market organizations.

Life Sciences
Articles

Gene therapy competitive dynamics: Winner takes all?

This article was originally published in Cell & Gene. It has also been published in Cell & Gene‘s sister publication, OutSourced Pharama. With many gene...
Life Sciences
Articles

Reducing prescription drug costs for seniors: The ABCs of ASP for Part D

As we move into 2021, it is time to take stock of the myriad proposals related to making prescription drugs more affordable for patients. Both political...

Life Sciences Strategy
Sponsorship & Speaking Engagement

August 24-27, 2020

Virtual

World Orphan Drug Congress USA 2020

CRA is a proud sponsor and exhibitor of this event. Andy Parece and Matt Majewski are presenting their study on the topic of “New Findings: US-based payer,...

Matthew Majewski

New York +1-212-520-7260 mmajewski@crai.com

Matthew Majewski

Latest Insights

Gene therapy competitive dynamics: Winner takes all?

Reducing prescription drug costs for seniors: The ABCs of ASP for Part D

Recent Events

World Orphan Drug Congress USA 2020

Credentials